The News Review:

- UF to Lead Research on Life-threatening Fungus
- Nutrition Research Journal Study Reports EpiCor’s Immunomodulating…
- Summer science program still inspiring students
- WA biotech applications reveal some info leave out plenty
- Netherlands Corporate News – CE en mede-oprichter Tarek Sherif van…
- Takeda Responds to the FDA Advisory Committee Recommendation
- Genstar Capital to acquire PRA International in $790m transaction

UF to Lead Research on Life-threatening Fungus
DentalPlans.com – Jul 31, 2007
both infectious disease experts with UF’s College of Medicine; Lindsey Baden M. director of clinical research in the division of infectious diseases at Brigham and Women’s Hospital and of infectious diseases at Dana-Farber; Angela Caliendo M. director of the medical microbiology and molecular diagnostics laboratories at Emory; David Denning M.

Nutrition Research Journal Study Reports EpiCor’s Immunomodulating…
npicenter.com – Jul 31, 2007
This dried complex fermentation product is derived from a proprietary process consisting of Saccharomyces cerevisiae and the medium in which it is grown. EpiCor received self-affirmed GRAS status in May 2006 from an expert panel comprised of members with extensive Food and Drug Administration (FDA) Environmental Protection Agency (EPA) and National Institute of Health (NIH) experience. Clinical research on EpiCor has been presented at the Federation of American Societies for Experimental Biology (FASEB) Conference and the American College of Nutrition (ACN) Symposium. For more information on EpiCor visit embriahealth. For an abstract of this study please contact Amanda Holty at 801.

Summer science program still inspiring students
Pittsburgh Post-Gazette – Pittsburgh Post Gazette – Jul 31, 2007
“Itplayed a significant role in my career. “That summer experience encouraged me to go into the field I’min. It excited me to want to pursue a career in clinical researcheven more. Andreea Manolache 17 of Upper St. Clair is undecided onwhether she’ll be an architect an engineer or biologist. She’shoping the time she spent this summer at Carnegie Mellon will helpher decide. “I wanted to be challenged outside of school” she said.

WA biotech applications reveal some info leave out plenty
kgw.com – Jul 31, 2007
But don’t try finding out what they might want to study — it’s part of the broad swath of information kept secret in the Life Science Discovery Fund’s response to a public records request from The Associated Press. According to data released Monday the first round of about 75 grant requests ranges from $1. 86 million sought by Elaine Peskind at the Seattle Institute for Biomedical and Clinical Research to $169500 sought by David Newell of the Seattle Neuroscience Institute at Swedish Hospital. What’s impossible to tell from the applications is whether they’re studying brain cancer heart disease or anything else. All keywords about the research descriptions of its specific aims and the entire 500-word abstract have been kept from public view. ther details being kept secret include:_ Names of other researchers participating in the projects.

Netherlands Corporate News – CE en mede-oprichter Tarek Sherif van…
Netherlands Corporate News – Netherlands Corporate News (persbericht) – Jul 31, 2007
About PharmaVICE PharmaVICE is expressly written and designed to deliver theviews opinions and insights of executives who are shaping thedirection of the dynamic life-sciences industry. PharmaVICE reachesmore than 17000 readers every month. About Medidata Solutions Worldwide Medidata Solutions helps the world’s leading pharmaceuticalbiotechnology medical device and research organizations maximize thevalue of their clinical research investments. Innovative processdesign technology and services streamline clinical trials byproviding early visibility to reliable clinical data – the lifebloodof every research organization. Working with companies andinstitutions both large and small Medidata Solutions helps clinicalresearchers safely accelerate the process of bringing life-enhancingtreatments to market – on six continents and in more than 80countries. Medidata Solutions brings significant value to its broadclient base with deep clinical experience and expertise in more than20 therapeutic areas projects in Phase I II III IV registries andsurveillance and studies with thousands of investigators andtens-of-thousands of subjects. For more information please visitwww.

Takeda Responds to the FDA Advisory Committee Recommendation
ITNews – Jul 31, 2007
is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited and is responsible for Takeda’s clinical research and development in the U. Takeda Pharmaceutical Company Limited located in saka Japan is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products.

Genstar Capital to acquire PRA International in $790m transaction
AltAssets – Jul 31, 2007
The transaction is valued at approximately $790m. Genstar is already a beneficial owner of 12. 8 per cent of the outstanding PRA shares. Under the terms of the agreement PRA stockholders will be entitled to receive $30.